Latest News & Updates

Breaking News

  • 2 hours ago

  • Simantini Singh Deo

RxSight Appoints Aziz Mottiwala As President And CEO In Planned Leadership Transition
Breaking News
Angelini Pharma Completes Catalyst Pharmaceuticals Acquisition To Expand Global Brain Health Business

Simantini Singh Deo

Other trending news you may like to read

RxSight Appoints Aziz Mottiwala As President And CEO In Planned Leadership Transition

RxSight appoints Aziz Mottiwala as President and CEO, succeeding Ron Kurtz in planned leadership transition.

Simantini Singh Deo

Pharma Now

Angelini Pharma Completes Catalyst Pharmaceuticals Acquisition To Expand Global Brain Health Business

Angelini Pharma completes Catalyst Pharmaceuticals acquisition to expand its global brain health business.

Simantini Singh Deo

Pharma Now

Diagonal Therapeutics Doses First Patient In Phase 1/2 Trial Of DIAG723 For Rare Vascular Disorder HHT

Diagonal Therapeutics doses first patient in Phase 1/2 trial of DIAG723 for hereditary hemorrhagic telangiectasia.

Simantini Singh Deo

Pharma Now

Plus Therapeutics Partners With Genomic Testing Cooperative To Expand CNSide Precision Oncology Platform

Plus Therapeutics partners with Genomic Testing Cooperative to expand its CNSide precision oncology platform.

Simantini Singh Deo

Pharma Now